Vanderbilt In Vivo Cellular and Molecular Imaging Center (VICMIC)


Deadlines:

  • Application must be received by July 15, 2009

  • Announcement of awards will be made by August 1, 2009

  • funding will be begin September 1, 2009

Download the PDF version here.

 

-------------------------------------------------------------------------------------

Today’s Science Student
Tomorrow’s Leader


The National Institute of Allergy and Infectious Diseases (NIAID) is the second largest Institute at the National Institutes of Health (NIH). NIAID is recognized worldwide for cutting-edge medical and scientific research. Our research programs aim to improve diagnosis, treatment, and prevention of immunological, allergic, and emerging and re-emerging infectious diseases.


Want to improve global health in the 21st century?
NIAID wants to train you.


The Intramural NIAID Research Opportunities (INRO) program is for students with strong academic standing who are from populations underrepresented in biomedical research.


Selected applicants will:


• Interview with scientists for potential research training positions.
• Hear scientific lectures from world-renowned scientists.
• Tour Institute laboratories and see the state-of-the-science technologies.

The 4-day exploratory program takes place in Bethesda, MD, on the NIH campus, February 1–4, 2010.

Student expenses for travel, hotel accommodations, and meals will be paid.

Applications accepted between August 15 and October 15, 2009.

To learn more about INRO, to check eligibility, and to apply, visit:

http://www.niaid.nih.gov/labs/training/inro.

 

Download the PDF version here.

 

banner

    Department of Health and Human Services
    National Institutes of Health
    National Institute of Allergy and Infectious Diseases
 

Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Copyright © 2009 Vanderbilt University School of Medicine
The Office of Biomedical Research Education & Training All rights reserved.
For questions or problems concerning this page, please submit a help ticket .